The National Asthma Council Australia (NAC) has announced the appointment of Pharmaceutical Society of Australia (PSA) nominee Dr Amanda Cross to the board.
The National Asthma Council Australia (NAC) has announced the appointment of Pharmaceutical Society of Australia (PSA) nominee Dr Amanda Cross to the ...
GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results